Stay updated with breaking news from Crl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Baillie Gifford & Co. lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 6.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,572 shares of the medical research company’s stock after selling 5,524 shares during the period. […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares rose 7.3% during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $237.16 and last traded at $236.41. Approximately 459,031 shares traded hands during mid-day trading, a decline of 17% from the average daily volume of […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Guggenheim from a “buy” rating to a “neutral” rating in a report issued on Thursday, Briefing.com reports. Other analysts have also issued research reports about the stock. Citigroup boosted their price target on shares of Charles River Laboratories International from […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price objective raised by equities researchers at UBS Group from $270.00 to $290.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. UBS Group’s price target would suggest a potential […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target lifted by Evercore ISI from $260.00 to $265.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s target price would indicate a potential upside of 8.54% from […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) announced its earnings results on Wednesday. The medical research company reported $2.46 earnings per share for the quarter, topping the consensus estimate of $2.39 by $0.07, Briefing.com reports. Charles River Laboratories International had a net margin of 11.27% and a return on equity of 18.15%. The […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) released its earnings results on Wednesday. The medical research company reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.39 by $0.07, Briefing.com reports. The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $991.25 million. […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 10.900-11.400 for the period, compared to the consensus earnings per share estimate of 10.790. The company issued revenue guidance of $4.2 billion-$4.3 billion, compared to the […]
By Denny Jacob Charles River Laboratories International shares were up 8.7% at $239.28 following its guidance for 2024. The stock, down about 5% over the...
State of New Jersey Common Pension Fund D decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 28,786 shares of the medical research company’s stock after selling 806 shares during the […]